Ali Behbahani Insider Profile
11 Followers
Ali Behbahani, Director at Monte Rosa Therapeutics, holds 6.69M shares in Monte Rosa Therapeutics (Ticker: GLUE), holds 4.55M shares in Black Diamond Therapeutics (Ticker: BDTX), holds 0.00 shares in Arcellx Inc (Ticker: ACLX).
Ali Behbahani Monte Rosa Therapeutics (GLUE)Director
Monte Rosa Therapeutics (GLUE)
Director
Ranked #101,447 out of 108,437 Corporate Insiders
Profitable Transactions
5 out of 21 Profitable Transactions
Average Return
-23.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ali Behbahani holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 19, 2025 - Today
Return:+51.60%
The most profitable trade made by Ali Behbahani
Ali Behbahani's Trading History
Monte Rosa Therapeutics
Jul 06, 2026
Director
Uninformative Buy
―
$105.87M
CVRx
Dec 18, 2023
Director
Uninformative Buy
72.68
$748.92
NeueHealth Inc
Oct 06, 2025
―
Uninformative Buy
6.81K
$0.00
Minerva Surgical
Jun 14, 2022
Director
Uninformative Buy
120.00K
―
Arcellx Inc
Apr 28, 2026
―
Uninformative Sell
―
$0.00
Savara
Jul 19, 2023
Ten Percent Owner
Informative Buy
1000.00K
$140.22M
Korro Bio
Mar 12, 2026
Director
Uninformative Buy
2.30M
$17.51M
MBX Biosciences, Inc.
Sep 17, 2024
Ten Percent Owner
Uninformative Buy
―
$239.10M
SpyGlass Pharma
Feb 11, 2026
Director, Ten Percent Owner
Uninformative Buy
―
$185.99M
Nevro Corp
May 23, 2018
―
Uninformative Buy
―
$31.48K
Adaptimmune Therapeutics
Aug 19, 2025
Director
Informative Sell
195.00K
$0.00
Genocea Biosciences
May 26, 2022
Director, Ten Percent Owner
Informative Sell
711.52K
―
Crispr Therapeutics AG
Aug 14, 2020
Director
Uninformative Buy
―
$14.45K
Regulus
May 09, 2019
―
Informative Buy
1.23M
$16.75M
Trevi Therapeutics
Apr 13, 2022
Ten Percent Owner
Informative Buy
6.80M
$202.39M
Mirum Pharmaceuticals
Jun 15, 2023
Ten Percent Owner
Uninformative Buy
―
$215.80M
Black Diamond Therapeutics
Jun 22, 2026
Director
Uninformative Buy
14.88K
$9.01M
Oyster Point Pharma
Jan 04, 2023
―
Uninformative Sell
―
$0.00
AKOUOS
Dec 02, 2022
―
Uninformative Sell
―
$0.00
Nkarta
―
Director
―
―
Metacrine
Dec 27, 2021
―
Informative Sell
493.91K
$1.49M
List of latest transactions for each holding click on a transaction to see Ali Behbahani's performance on stock
You May Also Like
Ali Behbahani insider profile FAQ
What is the percentage of profitable transactions made by Ali Behbahani?
The percentage of profitable transactions made by Ali Behbahani is 24%.
What is the average return per transaction made by Ali Behbahani?
The average return per transaction made by Ali Behbahani is -23.60%.
What stocks does Ali Behbahani hold?
Ali Behbahani holds: GLUE, CVRX, NEUE, UTRS, ACLX, SVRA, KRRO, MBX, SGP, NVRO, ADAPY, GNCAQ, CRSP, RGLS, TRVI, MIRM, BDTX, OYST, AKUS, NKTX, MTCR stocks.
What was Ali Behbahani’s latest transaction?
Ali Behbahani latest transaction was an Uninformative Buy of ―.
What was Ali Behbahani's most profitable transaction?
Ali Behbahani’s most profitable transaction was an Informative Sell of ADAPY stock on August 19, 2025. The return on the trade was 51.60%.
What is Ali Behbahani's role in Monte Rosa Therapeutics?
Ali Behbahani's role in Monte Rosa Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.